Maha Hussain, M.D.
Northwestern University, United States of America · University of Michigan Rogel Cancer Center · University of Michigan
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Maha Hussain, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:51 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT02987543 · Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)AstraZeneca · completed · Metastatic Castration-resistant Prostate Cancer · principal investigator
- Ph2NCT00780975 · A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate CancerPharmaMar · terminated · Prostate Cancer · principal investigator
- Ph2NCT00645593 · Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial CancerUniversity of Michigan Rogel Cancer Center · completed · Bladder Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.